Low Titers of Antidonor ABO Antibodies After ABO-Incompatible Living Donor Liver Transplantation: A Long-Term Follow-Up Study

Low Titers of Antidonor ABO Antibodies After ABO-Incompatible Living Donor Liver Transplantation: A Long-Term Follow-Up Study

Background. The ABO blood-type barrier in kidney and liver transplantation has been overcome by aggressive treatments such as B cell depletion using rituximab. However, the long-term effects of ABO-incompatible liver transplantation (ABO-I LTx) on immunological status have not previously been studie...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Daisuke Ueda, MD, Atsushi Yoshizawa, MD, PhD, Masakatsu Kaneshiro, MD, Yoshihiro Hirata, MD, PhD, Shintaro Yagi, MD, PhD, Koichiro Hata, MD, PhD, Hideaki Okajima, MD, PhD, Hiroto Egawa, MD, PhD, Shinji Uemoto, MD, PhD
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: Wolters Kluwer 2019-01-01
Ráidu:Transplantation Direct
Liŋkkat:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000858

Interneahtta

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000858

Geahča maid